Telling empowering stories, South Africans want to hear

Saturday, 16 October 2021 21:31

Covid-19 Daily Update: SA records 619 new cases with 25 related deaths.

By Lehlohonolo Lehana.

The National Institute for Communicable Diseases (NICD),reports 619 new COVID-19 cases that have been identified in South Africa, which brings the total number of laboratory-confirmed cases to 2,916,179. This increase represents a 2.2% positivity rate. 

The majority of new cases today are from Western Cape (21%), followed by KwaZulu-Natal accounting for 19%. Gauteng accounted for 15%; Eastern Cape and Free State each accounted for 11% respectively; Northern Cape accounted for 9%; North West accounted for 7%; Mpumalanga accounted for 5%; and Limpopo accounted for 3% of today’s new cases.

NICD said a further 25 COVID-19 related deaths have been reported, bringing total fatalities to 88,587 to date.

Health minister, Dr Joe Phaahla, has announced that the Ministerial Advisory Committee (MAC) on COVID-19 Vaccines has advised that additional doses be given to individuals with compromised immunity.

This includes those who are on long-term oral steroid therapy for autoimmune conditions and various treatments for haematological or immune malignancies.

The group will also comprise those with solid organ or bone marrow transplants, renal dialysis and primary immunological disorders.

"The advice is that these categories of patients be offered an additional dose over the prescribed normal, but this must be strictly under the referral by their medical doctor under their supervision,"Phaahla explained.

Johns Hopkins Medicine defines a Covid-19 booster shot as an additional dose of a vaccine given after the protection provided by the original shot(s) has begun to decrease over time, which is designed to help people maintain their level of immunity for longer.

The Minister was on Friday addressing a media briefing on government efforts in the fight against Covid-19 and the national vaccination rollout programme.

He also touched on the matter by some healthcare workers who were vaccinated under the Sisonke Study with Johnson & Johnson (J&J), who are calling to be considered for booster Covid-19 vaccine doses as eight months have passed since their first jab.

"The request is receiving attention and we are working with the South African Medical Research Council (SAMRC) on a possible approach," he said.

In addition, he said the SAMRC has since applied to the South African Health Products Regulatory Authority (SAHPRA) to consider a J&J booster to follow the Sisonke Study.

According to the Minister, this will be subsequently used in the second study on the possible benefit of enhanced immunity with a booster of the otherwise one dose vaccine.

The first study commenced on 17 February 2021 and concluded on 17 May 2021, reaching over 470 000 healthcare workers in over 120 sites across the country.

He also spoke about another issue of people who come from other countries have received vaccines, which are not used now in South Africa.

According to Phaahla these are either foreign nationals who reside in South Africa, had gone home, and received a vaccine such as AstraZeneca, Moderna, Sputnik or Sinovac.

"We are not able to provide second doses where they are required and neither can we give them a vaccine certificate when they need one."

However, the Minister said his department has received a recommendation that these individuals can be offered one dose of Pfizer to complete their two doses, as there is evidence that AstraZeneca and Moderna combine well with Pfizer.